Detalhe da pesquisa
1.
Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Int J Mol Sci;
25(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38674157
2.
ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Int J Mol Sci;
23(20)2022 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36293469
3.
Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Tumour Biol;
43(1): 11-26, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33935126
4.
p53, miR-34a and EMP1-Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells.
Int J Mol Sci;
20(17)2019 Aug 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31450568
5.
TREFOIL FACTOR FAMILY 1 EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN PATIENTS WITH RETINOBLASTOMA.
Retina;
38(12): 2422-2428, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29016460
6.
Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.
Int J Cancer;
141(3): 549-560, 2017 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28481041
7.
Re-characterization of established human retinoblastoma cell lines.
Histochem Cell Biol;
143(3): 325-38, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25326674
8.
Epigenetic control of trefoil factor family (TFF) peptide expression in human retinoblastoma cell lines.
Cell Physiol Biochem;
34(3): 1001-14, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25199519
9.
α-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells.
Cell Death Discov;
10(1): 27, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38225236
10.
Gastric Inhibitory Polypeptide Receptor (GIPR) Overexpression Reduces the Tumorigenic Potential of Retinoblastoma Cells.
Cancers (Basel);
16(9)2024 Apr 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38730608
11.
New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB.
Mol Oncol;
18(4): 832-849, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38217258
12.
High trefoil factor 1 (TFF1) expression in human retinoblastoma cells correlates with low growth kinetics, increased cyclin-dependent kinase (CDK) inhibitor levels and a selective down-regulation of CDK6.
Histochem Cell Biol;
139(2): 323-38, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22983508
13.
Tumor Suppressor Role of INPP4B in Chemoresistant Retinoblastoma.
J Oncol;
2023: 2270097, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36993823
14.
Trefoil Family Factor Peptide 1-A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy.
Cancers (Basel);
15(19)2023 Oct 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37835522
15.
Novel Function of Cancer Stem Cell Marker ALDH1A3 in Glioblastoma: Pro-Angiogenesis through Paracrine PAI-1 and IL-8.
Cancers (Basel);
15(17)2023 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37686698
16.
Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas.
Bioengineering (Basel);
10(4)2023 Apr 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37106651
17.
Loss at chromosome arm 16q in retinoblastoma: confirmation of the association with diffuse vitreous seeding and refinement of the recurrently deleted region.
Genes Chromosomes Cancer;
50(5): 327-37, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21305643
18.
Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo-Influence of Different Culture Conditions.
Methods Protoc;
5(2)2022 Mar 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35314658
19.
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.
Mol Oncol;
16(4): 957-981, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34228897
20.
5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology.
J Orthop Surg Res;
17(1): 34, 2022 Jan 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35033148